Guided Therapeutics Inc. (OTCMKTS:GTHP) Sees Large Growth in Short Interest

Guided Therapeutics Inc. (OTCMKTS:GTHP) was the target of a large increase in short interest in September. As of September 15th, there was short interest totaling 6,822 shares, an increase of 55.0% from the August 31st total of 4,400 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 19,766 shares, the short-interest ratio is currently 0.3 days.

Guided Therapeutics Price Performance

Shares of GTHP stock opened at $0.22 on Friday. Guided Therapeutics has a 12 month low of $0.15 and a 12 month high of $0.54. The firm has a market capitalization of $21.24 million, a P/E ratio of -5.50 and a beta of 0.70. The company’s fifty day moving average price is $0.25 and its two-hundred day moving average price is $0.24.

Guided Therapeutics (OTCMKTS:GTHP) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.01) earnings per share for the quarter.

About Guided Therapeutics

Guided Therapeutics, Inc is a medical technology company focused on developing diagnostic products for the detection of cancer and precancerous conditions. Its technology is based on biophotonic tissue analysis, which uses light to identify changes in tissue that may be associated with disease.

The company’s principal product is LuViva Advanced Cervical Scan, a noninvasive diagnostic device designed to evaluate cervical tissue for abnormalities associated with cervical cancer and precancer.